Home Cart Sign in  
Chemical Structure| 1716-12-7 Chemical Structure| 1716-12-7

Structure of Sodium 4-Phenylbutyrate
CAS No.: 1716-12-7

Chemical Structure| 1716-12-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sodium 4-phenylbutyrate (4-PBA sodium) is an inhibitor of HDAC and endoplasmic reticulum (ER) stress, utilized in cancer and infection research.

Synonyms: 4-PBA sodium; 4-Phenylbutyric acid sodium; TriButyrate

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sodium 4-Phenylbutyrate

CAS No. :1716-12-7
Formula : C10H11NaO2
M.W : 186.18
SMILES Code : O=C([O-])CCCC1=CC=CC=C1.[Na+]
Synonyms :
4-PBA sodium; 4-Phenylbutyric acid sodium; TriButyrate
MDL No. :MFCD00800247
InChI Key :VPZRWNZGLKXFOE-UHFFFAOYSA-M
Pubchem ID :5258

Safety of Sodium 4-Phenylbutyrate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H319
Precautionary Statements:P305+P351+P338

Related Pathways of Sodium 4-Phenylbutyrate

epigenetics

Isoform Comparison

Biological Activity

Target
  • HDAC

In Vitro:

Cell Line
Concentration Treated Time Description References
rat heart cells 10 mM 30 min relieves ER stress and improves contractile function J Am Heart Assoc. 2013 May 17;2(3):e004796.
MDA-MB-231 cells 20 μM 24 h Reduce UPR activation and protect cells from apoptosis Cell Death Dis. 2013 Jul 18;4(7):e732.
HeLa cells 5 mM 4 h To evaluate the effect of 4-PBA on GRP78 protein levels and caspase-12 activity. 4-PBA significantly reduced the increase of GRP78 induced by δ-T3 and TRF treatment and significantly inhibited the γ-T3- and δ-T3-induced increase of caspase-12 activity. Genes Nutr. 2016 Dec 23;11:32.
bone marrow-derived early outgrowth cells (EOCs) 50 μM 7 days To investigate the effect of ER stress on EOC function under high glucose conditions, 4-phenylbutyrate significantly alleviated HG-induced ER stress, apoptosis, and functional impairment. Diabetologia. 2015 Sep;58(9):2181-90.
Tomato plant leaves 1 mM 6 h To evaluate how a chemical chaperone modulates Tm-induced ER stress, it was found that it decreased the Tm-induced increase in SlBiP, SlIRE1a, and SlBI1 transcripts Biomolecules. 2020 Jul 10;10(7):1031.
Human Brain Microvascular Endothelial Cells (HBMECs) 10 μM 1 h Inhibition of Tat-induced ER stress and apoptosis Mol Neurobiol. 2016 Jan;53(1):132-142.
ND1-mutant cybrids 1 mM 48 h To investigate the protective effects of 4-Phenylbutyrate on ND1-mutant cells under energetic stress conditions. Results showed that 4-Phenylbutyrate partially attenuated the expression of ER stress markers such as Bip/GRP78, CHOP, and sXBP1 mRNA levels. Cell Death Dis. 2018 May 31;9(6):658.
NIH-3T3 cells 20 μM 24/48 h Increase cell folding capacity, reduce UPR activation, and protect transformed cells from death Cell Death Dis. 2013 Jul 18;4(7):e732.
human hepatocytes (from OTCD patients) 0.01, 0.1, and 1 mM 2 weeks To evaluate the effect of 4-PB and SB on reducing ammonia levels in hepatocytes from OTCD patients. Results showed that 4-PB treatment was more effective than SB, and hetero-OTCD hepatocytes were more susceptible than hemi-OTCD hepatocytes. J Inherit Metab Dis. 2021 May;44(3):618-628.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
ApoE-/- mice 5/6 nephrectomy-induced chronic kidney disease model Intraperitoneal injection 250 mg/kg Once daily for 8 weeks To investigate the effect of 4-PBA on CKD-dependent vascular calcification. Results showed that 4-PBA treatment significantly reduced aortic calcified lesions. J Am Heart Assoc. 2013 Sep 5;2(5):e000238
Rats Neonatal ventral hippocampal lesion model Subcutaneous injection 20 mg/kg Daily from the day after surgery until adulthood (week 9) To investigate whether the HDAC inhibitor phenylbutyrate could counteract long-term consequences of neonatal ventral hippocampal lesions in rats. Results showed that phenylbutyrate treatment reduced hypersensitivity of the dopaminergic system and deterioration of associative learning, but did not affect anxiety or anatomical brain changes. Front Psychiatry. 2011 Jan 7;1:153

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00999167 Cirrhosis Hep... More >>atic Encephalopathy Less << Phase 2 Completed - -
NCT01135680 Drug Toxicity Phase 1 Completed - United States, Wisconsin ... More >> Covance Clinical Pharmacology, Inc. Madison, Wisconsin, United States, 53704 Less <<
NCT00999167 - Completed - -
NCT01347073 Urea Cycle Disorders Phase 3 Completed - United States, California ... More >> UCLA Pediatrics/Genetics Los Angeles, California, United States, 90404 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Maine Maine Medical Center Portland, Maine, United States, 04101 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT01948427 - Recruiting September 2026 United States, Pennsylvania ... More >> United BioSource Corporation Recruiting Blue Bell, Pennsylvania, United States, 19422 Contact: THRIVE Registry Team    855-823-2595    thriveregistry@unitedbiosource.com Less <<
NCT03488524 Amyotrophic Lateral Sclerosis ... More >> ALS Less << Phase 2 Recruiting January 1, 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Aileen Shaughnessy, MA    617-724-9196    ANSHAUGHNESSY@mgh.harvard.edu    Principal Investigator: James Berry, MD          University of Massachusetts Memorial Medical Center Recruiting Worcester, Massachusetts, United States, 01655 Contact: Diane McKenna-Yasek, RN, BSN    508-856-4697    diane.mckenna-yasek@umassmed.edu    Principal Investigator: Margaret Owegi, DO Less <<
NCT00067756 Alpha 1-Antitrypsin Deficiency PHASE2 COMPLETED 2025-10-03 University of Florida, Gainesv... More >>ille, Florida, 32610, United States Less <<
NCT02094222 - - - -
NCT00947297 - Completed - -
NCT00771901 - Completed - -
NCT01347073 - Completed - -
NCT01257737 Urea Cycle Disorders Phase 4 Completed - United States, California ... More >> UCLA Pediatrics/Genetics Los Angeles, California, United States, 90095 Stanford University School of Medicine Palo Alto, California, United States, 94305 United States, Colorado Denver Children's Hospital Aurora, Colorado, United States, 80045 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Maine Maine Medical Center Portland, Maine, United States, 04102 United States, Minnesota University of Minnesota Medical Center Minneapolis, Minnesota, United States, 55454 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania Children's Hospital of Pittsburg of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Less <<
NCT00771901 Insulin Resistance ... More >> Diabetes Obesity Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT00004767 Amino Acid Metabolism, Inborn ... More >>Errors Less << Phase 2 Completed - -
NCT00947297 Urea Cycle Disorders Phase 3 Completed - -
NCT03533257 Alzheimer Disease Phase 2 Recruiting September 1, 2020 United States, Illinois ... More >> Rush University Medical Center Recruiting Chicago, Illinois, United States, 60612 Contact: Judy Phillips    312-942-0050    Judy_Phillips@rush.edu    United States, Kansas University of Kansas Clinical Research Center Recruiting Fairway, Kansas, United States, 66205 Contact: KUMC Recruitment Division    913-588-0555    KUAMP@kumc.edu    United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Alison J McManus, DNP    617-643-4848    ajmcmanus@mgh.harvard.edu    Contact: John Ernandez    617-643-4047    jernandez@partners.org    United States, New Jersey Rowan University Not yet recruiting Stratford, New Jersey, United States, 08084 Contact: Lauren Fedor    856-566-6003    fedor@rowan.edu    United States, New York Mount Sinai Alzheimer's Disease Research Center Not yet recruiting New York, New York, United States, 10029 Contact: Caroline Meuser    212-659-8885    caroline.meuser@mssm.edu    Columbia University Recruiting New York, New York, United States, 10032 Contact: Ruth Tejeda    212-305-7661    rbt41@cumc.columbia.edu    United States, Pennsylvania Penn Memory Center Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Laura Schankel    215-349-8727    laura.schankel@pennmedicine.upenn.edu Less <<
NCT00006239 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT01257737 - Completed - -
NCT00986895 Hepatic Encephalopathy ... More >> Urea Cycle Disorders Less << Phase 1 Completed - Ukraine ... More >> National University of Pharmacy Kharkiv, Ukraine, 61057 Department of General Surgery #2; Kharkiv State Medical University Kharkiv, Ukraine, 61128 Less <<
NCT00387530 Gastric Cancer ... More >> Head and Neck Cancer Lymphoma Lymphoproliferative Disorder Less << Phase 2 Unknown - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 Less <<
NCT00005934 Beta Thalassemia Phase 2 Completed - United States, Maryland ... More >> National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States, 20892 Less <<
NCT03127514 Amyotrophic Lateral Sclerosis ... More >> Motor Neuron Disease Neuromuscular Diseases Neurodegenerative Diseases Spinal Cord Diseases TDP-43 Proteinopathies Nervous System Diseases Central Nervous System Diseases Less << Phase 2 Recruiting May 2019 -
NCT02343094 Proteinuric Diseases Phase 2 Phase 3 Completed - France ... More >> Hôpital Necker Enfants Malades Paris, France, 75015 Less <<
NCT02246218 Urea Cycle Disorder Phase 4 Completed - United States, California ... More >> Kaiser Permanente Regional Metabolic Center Los Angeles, California, United States, 90027 Stanford Center for Clinical & Translational Research & Education Palo Alto, California, United States, 94034 United States, District of Columbia Children's National Medical Center Washington, D.C., District of Columbia, United States, 20010 United States, Florida Shands at University of Florida Gainesville, Florida, United States, 32610 United States, Georgia Emory University Decatur, Georgia, United States, 30033 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Maine Maine Medical Center Portland, Maine, United States, 04102 United States, Michigan Children's Hospital of Michigan Detroit, Michigan, United States, 48201 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Ohio University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15224 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada The Hospital for Sick Children Toronto, Canada, M5G 1Hs Less <<
NCT00006240 Leukemia Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 National Heart, Lung, and Blood Institute Bethesda, Maryland, United States, 20892 United States, New York Mount Sinai Medical Center, NY New York, New York, United States, 10029 United States, Pennsylvania University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15213-3489 Less <<
NCT00005639 Lymphoma Smal... More >>l Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT01881984 Medium-chain Acyl-CoA Dehydrog... More >>enase (MCAD) Deficiency Less << Phase 1 Completed - United States, Pennsylvania ... More >> Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 Less <<
NCT00006019 Leukemia Lung... More >> Cancer Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Prostate Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT02323100 Cystic Fibrosis Phase 1 Phase 2 Recruiting April 2020 United States, Alabama ... More >> University of Alabama at Birmingham Not yet recruiting Birmingham, Alabama, United States, 35294-0006 Contact: Steven M Rowe, MD, MSPH    205-934-9640    smrowe@uab.edu    Principal Investigator: Steven M Rowe, MD, MSPH          United States, Colorado National Jewish Health Recruiting Denver, Colorado, United States, 80206 Contact: Connie StClair    303-270-2321    shiven@njhealth.org    Principal Investigator: Noah Lechtzin, MD          Sub-Investigator: Peter Mogazel, MD, PhD          United States, Pennsylvania Children's Hospital of Philadelphia Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Ron Rubenstein, MD, PhD    215-590-1281    rrubenst@mail.med.upenn.edu    Principal Investigator: Ron Rubenstein, MD, PhD Less <<
NCT00016744 Cystic Fibrosis Phase 1 Phase 2 Completed - -
NCT01881984 - Completed - -
NCT00006450 Brain Tumor Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00590538 - Terminated(12/15/2008 Voluntar... More >>ily placed on inactive status-requested by the PI) Less << - -
NCT00590538 Cystic Fibrosis Phase 1 Phase 2 Terminated(12/15/2008 Voluntar... More >>ily placed on inactive status-requested by the PI) Less << - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00992459 Urea Cycle Disorders Phase 3 Completed - -
NCT00977600 Healthy Phase 1 Completed - Ukraine ... More >> Medical Sanitary Division #2 Kharkiv, Ukraine, 61011 Less <<
NCT00439569 Spinal Muscular Atrophy Type I... More >>I Spinal Muscular Atrophy Type III Less << Phase 1 Phase 2 Terminated(Due to poor complia... More >>nce with study drug administration.) Less << - United States, California ... More >> Stanford University Medical Center, 300 Pasteur Drive, Room A343 Stanford, California, United States, 94305-5235 United States, Missouri Washington University Medical School, Washington University, 660 S. Euclid Avenue, Box 8111 St. Louis, Missouri, United States, 63110 United States, New York Columbia University, 180 Fort Washington Avenue, 5th Floor New York, New York, United States, 10032 United States, Pennsylvania The Children's Hospital of Philadelphia, Clinical Trials Office, A-230, 34th St. and Civic Center Boulevard Philadelphia, Pennsylvania, United States, 19104-4399 United States, Texas University of Texas Southwestern Medical Center at Dallas, Division of Pediatric Neurology, Children's Medical Center of Dallas, Ambulatory Care Pavilion, 2350 Stemmons Freeway, Suite #5074 Dallas, Texas, United States, 75207 Less <<
NCT00001565 Brain Neoplasms ... More >> Neuroblastoma Less << Phase 1 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00004871 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00439569 - Terminated(Due to poor complia... More >>nce with study drug administration.) Less << - -
NCT00992459 - Completed - -
NCT00002909 Lymphoma Unsp... More >>ecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins Oncology Center Baltimore, Maryland, United States, 21287 Less <<
NCT01949766 - - - -
NCT00002796 Mucinous Adenocarcinoma of the... More >> Colon Mucinous Adenocarcinoma of the Rectum Recurrent Colon Cancer Recurrent Rectal Cancer Signet Ring Adenocarcinoma of the Colon Signet Ring Adenocarcinoma of the Rectum Stage IVA Colon Cancer Stage IVA Rectal Cancer Stage IVB Colon Cancer Stage IVB Rectal Cancer Less << Phase 1 Phase 2 Terminated(Administratively co... More >>mplete.) Less << - United States, New York ... More >> Mount Sinai Medical Center New York, New York, United States, 10029 Less <<
NCT00439218 Spinal Muscular Atrophy Type I Phase 1 Phase 2 Terminated(Extremely slow enro... More >>llment) Less << - United States, California ... More >> Stanford University Medical Center, 300 Pasteur Drive, Room A343 Stanford, California, United States, 94305-5235 United States, Massachusetts Children's Hospital, Boston, 300 Longwood Avenue, Fegan 11 Boston, Massachusetts, United States, 02115 United States, New York Columbia University, 180 Fort Washington Avenue, 5th Floor New York, New York, United States, 10032 United States, Pennsylvania The Children's Hospital of Philadelphia, Clinical Trials Office, A-230, 34th St. and Civic Center Boulevard Philadelphia, Pennsylvania, United States, 19104-4399 United States, Texas University of Texas Southwestern Medical Center at Dallas, Division of Pediatric Neurology, Children's Medical Center of Dallas, Ambulatory Care Pavilion, 2350 Stemmons Freeway, Suite #5074 Dallas, Texas, United States, 75207 Less <<
NCT03335488 Urea Cycle Disorder Phase 4 Recruiting March 31, 2020 United States, New York ... More >> Mount Sinai School of Medicine Recruiting New York, New York, United States, 10029 Contact: Dr. George Diaz, M.D., PhD.    212-241-0858    George.Diaz@mssm.edu    Contact: Luca Fierro    212 659 1477    luca.fierro@mssm.edu    Principal Investigator: Dr. George Diaz, M.D., PhD.          United States, Ohio University Hospitals Case Medical Center Recruiting Cleveland, Ohio, United States, 44106-6005 Contact: Dr. Jirair Bedoyan, MD    216-844-7124    Jirair.Bedoyan@UHhospitals.org    Contact: Audrey Lynn    216 844 7124    audrey.lynn@UHhospitals.org    United States, Pennsylvania Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Dr. Gerard Vockley, MD, PhD    412-692-7530    Jennifer.baker@chp.edu    Contact: Jennifer Baker    412-692-7530    Jennifer.baker@chp.edu    Principal Investigator: Dr. Gerard Vockley, MD, PhD          United States, Utah University of Utah Recruiting Salt Lake City, Utah, United States, 84132 Contact: Dr. Nicola Longo, M.D., PhD.    801-587-3605    Nicola.Longo@hsc.utah.edu    Contact: Carrie Bailey    801 587 3605    Carrie.Bailey@hsc.utah.edu    Principal Investigator: Dr. Nicola Longo, M.D., PhD.          Belgium Cliniques Universitaires Saint-Luc Recruiting Brussels, Belgium, 1200 Contact: Prof. Etienne Sokal, MD    32 2 764 13 87    etienne.sokal@uclouvain.be    Contact: Julia Versavau    32 2 764 19 33    julia.versavau@uclouvain.be    Principal Investigator: Prof. Etienne Sokal, MD          Spain Hospital Materno-Infantil (HRU Carlos Haya) Recruiting Málaga, Andalucia, Spain, 29006 Contact: Dr. Javier Blasco-Alonso, MD    34 951 29 21 91    javierblascoalonso@yahoo.es    Contact: Almudena Frias    34 951 29 21 91       Principal Investigator: Dr. Javier Blasco-Alonso          Hospital Clinico Universitario de Santiago Recruiting Santiago de Compostela, Galicia, Spain, 15706 Contact: Dr. Maria Luz Couce-Pico, MD    34 981 950 162    maria.luz.couce.pico@sergas.es    Contact: Maria Teresa Oreiro-Garcia    34 981 955 627    maria.teresa.oreiro.garcia@sergas.es    Principal Investigator: Dr. Maria Luz Couce-Pico, MD          Hospital Universitario de Cruces Recruiting Barakaldo, Vizcaya, Spain, 48903 Contact: Dr. Luis Jose Aldamiz-Echevar Azuara, MD    34 94 600 6327    LUISJOSE.ALDAMIZ-ECHEVARAZUARA@osakidetza.net    Contact: Fernando Olatz    34 94 600 6327    fernando.andradelodeiro@osakidetza.eus    Principal Investigator: Dr. Luis Jose Aldamiz-Echevar Azuara, MD          Switzerland Universitätsspital, Inselspital Bern Recruiting Bern, Switzerland, 3010 Contact: Matthias Gautchshi,, MD    41 (0)31 632 01 47    Matthias.Gautschi@insel.ch    Contact: Alexandra Nuoffer    +41 (0)31 632 51 37    alexandra.nuoffer@insel.ch    Principal Investigator: Dr. Matthias Gautchshi, MD          University Children's Hospital Recruiting Zurich, Switzerland, 75, 8032 Contact: Prof Johannes Häberle, MD    41- 44-266-7111    johannes.haeberle@kispi.uzh.ch    Contact: Ms. Doris Anzengruber    41- 44-266-7722    Doris.Anzengruber@kispi.uzh.ch    Principal Investigator: Prof Johannes Häberle, MD Less <<
NCT00528268 Spinal Muscular Atrophy Phase 1 Phase 2 Completed - United States, Utah ... More >> University of Utah Salt Lake City, Utah, United States, 84132 Less <<
NCT00439218 - Terminated(Extremely slow enro... More >>llment) Less << - -
NCT01784718 - - - -
NCT00528268 - Completed - -
NCT01702974 HIV Infection Phase 2 Completed - Ethiopia ... More >> Black Lion Hospital (BLH), Addis Ababa University, Faculty of Medicine Addis Ababa, Lideta sub city, Ethiopia Less <<
NCT00107770 Amyotrophic Lateral Sclerosis Phase 1 Phase 2 Completed - United States, Iowa ... More >> VA Medical Center, Iowa City Iowa City, Iowa, United States, 52246-2208 United States, Kentucky VA Medical Center, Lexington Lexington, Kentucky, United States, 40502 United States, Maryland VA Maryland Health Care System, Baltimore Baltimore, Maryland, United States, 21201 United States, Massachusetts Edith Nourse Rogers Memorial Veterans Hospital, Bedford Bedford, Massachusetts, United States, 01730 VA Medical Center, Jamaica Plain Campus Boston, Massachusetts, United States, 02130 United States, New York VA Medical Center, Syracuse Syracuse, New York, United States, 13210 United States, North Carolina VA Medical Center, Durham Durham, North Carolina, United States, 27705 United States, Ohio VA Medical Center, Cincinnati Cincinnati, Ohio, United States, 45220 United States, Pennsylvania VA Pittsburgh Health Care System Pittsburgh, Pennsylvania, United States, 15240 United States, Texas Michael E. DeBakey VA Medical Center (152) Houston, Texas, United States, 77030 Less <<
NCT00533559 Diabetes Insu... More >>lin Resistance Less << Phase 4 Completed - Canada, Ontario ... More >> Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT01698476 Pulmonary Tuberculosis (TB) Phase 2 Completed - Ethiopia ... More >> Black Lion Hospital (BLH), Addis Ababa University, Faculty of Medicine Addis Ababa, Lideta sub city, Ethiopia Less <<
NCT00947544 Urea Cycle Disorders Phase 2 Completed - United States, California ... More >> UCLA Los Angeles, California, United States, 90095 United States, District of Columbia The George Washington DC Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Pennsylvania University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15201 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Canada, Ontario The Hospital for Sick Children Toronto, Ontario, Canada, M5G1X8 Less <<
NCT01580007 Pulmonary Tuberculosis Phase 2 Completed - Bangladesh ... More >> National Institute of Diseases of Chest and Hospital (NIDCH) Dhaka, Bangladesh, 1212 Less <<
NCT00947544 - Completed - -
NCT00345605 Argininosuccinic Aciduria ... More >> Amino Acid Metabolism, Inborn Errors Urea Cycle Disorders Less << Phase 2 Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00345605 - Completed - -
NCT00551200 Urea Cycle Disorders Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Texas Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT03734263 Pyruvate Dehydrogenase Complex... More >> Deficiency Less << Phase 1 Phase 2 Recruiting October 1, 2019 Italy ... More >> Federico II University Recruiting Napoli, Italy, 80131 Contact: Nicola Brunetti-Pierri    +390817463288    brunetti@tigem.it Less <<
NCT01096095 Spinocerebellar Ataxia Type 3 Phase 2 Withdrawn(Regulatory authoriti... More >>es did not allow the entrance of the study drug in the country) Less << July 2011 Brazil ... More >> Hospital de Clínicas de Porto Alegre Porto Alegre, Rio Grande do Sul, Brazil, 90.035-903 Less <<
NCT02111200 Urea Cycle Disorders, Inborn Not Applicable Completed - United States, Texas ... More >> Children's Nutrition Research Center/Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT01529060 Maple Syrup Urine Disease Phase 2 Phase 3 Active, not recruiting December 2017 United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT02111200 - Completed - -
NCT00551200 - Completed - -
NCT00212316 Huntington's Disease Phase 2 Completed - United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States United States, California University of California—San Diego San Diego, California, United States United States, Iowa University of Iowa Hospital and Clinics Iowa City, Iowa, United States United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States United States, Maryland Johns Hopkins University Baltimore, Maryland, United States United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States United States, New York Columbia University New York, New York, United States University of Rochester Rochester, New York, United States Less <<
NCT02046434 Parkinson's Disease Phase 1 Active, not recruiting September 2018 United States, Colorado ... More >> University of Colorado Denver Anschutz Medical Center Aurora, Colorado, United States, 80045 Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.37mL

1.07mL

0.54mL

26.86mL

5.37mL

2.69mL

53.71mL

10.74mL

5.37mL

References

 

Historical Records

Categories